Wedell-Wedellsborg Johan
Insider CIK 1753185 · YMAB Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 16,000 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 33,450 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 11,000 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 16,000 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 32,000 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 36,000 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 13,950 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 14,545 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 11,000 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | U Tender | 2025-09-16 | 2025-09-18 | 5,825 | $8.60 | $50.1K | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | U Tender | 2025-09-16 | 2025-09-18 | 4,559,233 | $8.60 | $39.21M | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer | 2025-09-16 | 2025-09-18 | 25,080 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2025-06-30 | 2025-07-02 | 33,450 | — | $0 | 33,450 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award | 2025-06-30 | 2025-07-02 | 25,080 | — | $0 | 30,905 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2024-06-11 | 2024-06-13 | 14,545 | — | $0 | 14,545 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award | 2024-06-11 | 2024-06-13 | 3,495 | — | $0 | 5,825 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | P Buy | 2023-12-11 | 2023-12-11 | 102,863 | $7.01 | $721.1K | 4,552,778 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | P Buy | 2023-12-11 | 2023-12-12 | 6,455 | $6.85 | $44.2K | 4,559,233 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | P Buy | 2023-12-08 | 2023-12-11 | 18,503 | $6.99 | $129.3K | 4,449,915 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | P Buy | 2023-12-07 | 2023-12-11 | 6,183 | $6.50 | $40.2K | 4,431,412 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | P Buy | 2023-11-29 | 2023-12-01 | 51,837 | $5.97 | $309.5K | 4,425,229 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | P Buy | 2023-11-28 | 2023-11-29 | 30,671 | $5.81 | $178.2K | 4,373,392 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | P Buy | 2023-11-27 | 2023-11-29 | 62,516 | $5.49 | $343.2K | 4,342,721 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2023-06-08 | 2023-06-09 | 13,950 | — | $0 | 13,950 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award | 2023-06-08 | 2023-06-09 | 2,330 | — | $0 | 2,330 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | P Buy | 2023-05-15 | 2023-05-17 | 101,740 | $9.65 | $981.8K | 4,280,205 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2022-07-15 | 2022-07-19 | 16,000 | — | $0 | 16,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2021-06-10 | 2021-06-14 | 16,000 | — | $0 | 16,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-06-10 | 2021-06-11 | 11,229 | $36.15 | $405.9K | 4,178,465 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-06-09 | 2021-06-10 | 116,700 | $36.19 | $4.22M | 4,189,694 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-06-08 | 2021-06-10 | 33,300 | $35.28 | $1.17M | 4,306,394 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-06-07 | 2021-06-09 | 72,400 | $34.15 | $2.47M | 4,339,694 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-06-04 | 2021-06-07 | 3,841 | $34.03 | $130.7K | 4,412,094 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-06-03 | 2021-06-07 | 30,666 | $33.19 | $1.02M | 4,415,935 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-06-01 | 2021-06-02 | 6,864 | $35.57 | $244.2K | 4,446,601 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-05-28 | 2021-06-02 | 25,000 | $36.34 | $908.5K | 4,453,465 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | J Other | 2021-03-10 | 2021-03-12 | 1,029,927 | — | $0 | 4,478,465 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2020-06-23 | 2020-06-24 | 16,000 | — | $0 | 16,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | J Other | 2019-12-30 | 2019-12-31 | 498,392 | — | $0 | 5,508,392 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | J Other | 2019-12-30 | 2019-12-31 | 498,392 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2019-09-06 | 2019-09-09 | 5,791 | $27.00 | $156.4K | 498,392 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2019-09-05 | 2019-09-09 | 11,452 | $27.00 | $309.2K | 504,183 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2019-08-30 | 2019-09-03 | 100 | $27.00 | $2.7K | 515,635 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2019-08-29 | 2019-09-03 | 89,066 | $26.58 | $2.37M | 515,735 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2019-08-28 | 2019-08-29 | 29,552 | $27.02 | $798.5K | 604,801 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2019-08-27 | 2019-08-29 | 19,805 | $27.18 | $538.3K | 634,353 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2019-08-22 | 2019-08-26 | 990 | $27.75 | $27.5K | 654,158 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2019-08-21 | 2019-08-22 | 60,116 | $27.83 | $1.67M | 664,147 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2019-08-21 | 2019-08-26 | 60,116 | $27.83 | $1.67M | 655,148 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2019-08-20 | 2019-08-22 | 108,128 | $27.42 | $2.96M | 724,263 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2019-08-20 | 2019-08-26 | 108,128 | $27.42 | $2.96M | 715,264 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | J Other | 2019-07-15 | 2019-07-17 | 860,105 | — | $0 | 832,391 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | J Other | 2019-07-15 | 2019-08-26 | 860,105 | — | $0 | 823,392 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2019-06-12 | 2019-06-14 | 16,000 | — | $0 | 16,000 | SEC↗ |